Roche (OTCMKTS:RHHBY) Reaches New 1-Year High – Here’s Why

Shares of Roche Holding AG (OTCMKTS:RHHBY) hit a new 52-week high during trading on Monday . The stock traded as high as $43.96 and last traded at $43.06, with a volume of 4303336 shares traded. The stock had previously closed at $43.89.

Analysts Set New Price Targets

Several equities analysts recently commented on RHHBY shares. Morgan Stanley initiated coverage on Roche in a research report on Wednesday, February 12th. They set an “equal weight” rating for the company. Sanford C. Bernstein upgraded shares of Roche to a “strong-buy” rating in a research report on Thursday, January 30th. Finally, UBS Group upgraded shares of Roche from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 13th. Two analysts have rated the stock with a sell rating, one has given a hold rating, one has assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy”.

Roche Stock Performance

The company has a debt-to-equity ratio of 0.86, a current ratio of 1.26 and a quick ratio of 0.97. The business has a 50-day simple moving average of $39.01 and a 200-day simple moving average of $38.46.

Institutional Trading of Roche

Several hedge funds and other institutional investors have recently made changes to their positions in RHHBY. HighPoint Advisor Group LLC lifted its stake in shares of Roche by 2.8% in the 4th quarter. HighPoint Advisor Group LLC now owns 11,091 shares of the company’s stock valued at $387,000 after purchasing an additional 304 shares in the last quarter. Hantz Financial Services Inc. increased its holdings in shares of Roche by 0.9% in the fourth quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company’s stock valued at $1,176,000 after buying an additional 305 shares in the last quarter. Canopy Partners LLC boosted its stake in Roche by 4.6% in the 3rd quarter. Canopy Partners LLC now owns 7,772 shares of the company’s stock worth $310,000 after purchasing an additional 344 shares during the period. Brooklyn Investment Group raised its holdings in shares of Roche by 36.6% during the fourth quarter. Brooklyn Investment Group now owns 1,354 shares of the company’s stock worth $48,000 after acquiring an additional 363 shares in the last quarter. Finally, Altrius Capital Management Inc lifted its stake in Roche by 0.3% in the fourth quarter. Altrius Capital Management Inc now owns 183,448 shares of the company’s stock valued at $6,399,000 after acquiring an additional 603 shares during the last quarter.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.